[1] Mercier E, Tardif P A, Cameron P A, et al. Prognostic value of neuron-specific enolase (NSE) for prediction of post-concussion symptoms following a mild traumatic brain injury: a systematic review[J]. Brain Injury, 2018,32(1):29-40. [2] Mondello S, Schmid K, Berger R P, et al. The challenge of mild traumatic brain injury: role of biochemical markers in diagnosis of brain damage[J]. Med Res Rev, 2014,34(3):503-531. [3] 杨树源,张建宁.神经外科学[M].2版.北京:人民卫生出版社,2015:777-785. [4] 刘文祥.弥漫性轴索损伤患者颅脑CT表现与病情严重程度及预后的相关性分析[J].中国 CT和MRI杂志,2018,16(7):59. [5] Ramirez-Celis A, Edmiston E, Schauer J,et al. Peptides of neuron specific enolase as potential ASD biomarkers: From discovery to epitope mapping[J]. Brain Behav Immun, 2020, 84:200-208. [6] 黄纯真.重型颅脑损伤治疗方法的研究进展[J].中华神经创伤外科电子杂志,2015,1(1):45-48. [7] Matis G, Birbilis T. The Glasgow Coma Scale-a brief review. Past, present, future[J]. Acta Neurol Belg, 2008,108(3):75-89. [8] 黄志纯,田新华,丰伟,等.重型颅脑损伤患者血清NSE和MMPs的动态变化及临床意义[J].中华神经外科杂志,2014,30(1):67-70. [9] Zaheer S, Beg M, Rizvi I, et al. Correlation between serum neuron specific enolase and functional neurological outcome in patients of acute ischemic stroke[J]. Ann Indian Acad Neurol, 2013,16(4):504-508. [10]李玉艳,梁琳琳,刘晓勇.颅脑损伤患者脑脊液和血清神经元特异性烯醇化酶及髓鞘碱性蛋白水平变化及临床意义[J].国际检验医学杂志,2017,38(10):1338-1340. [11]邢莉莉,张敏,魏红霞,等.神经元特异性烯醇化酶在危重症患儿脑功能监测中价值及单唾液酸四己糖神经节苷酯早期治疗危重症患儿脑损伤效果[J].临床误诊误治,2018,31(8):90-94. [12]邹芳,王金龙,杜彪.急性脑梗死患者外周血Treg和NSE水平及与脑损伤程度的相关性研究[J].临床误诊误治,2020,33(10):105-108. [13]卢维新.基于多模态监测在重度颅脑损伤中的临床研究[D].兰州:兰州大学,2020. [14]王之涵,沙龙贵,任力,等.脑挫伤患者血清和脑脊液神经元特异性烯醇化酶及髓鞘碱性蛋白水平的改变[J].临床神经外科杂志,2018,15(5):380-383. [15]Vedin T, Bergenfeldt H, Holmström E,et al. Microwave scan and brain biomarkers to rule out intracranial hemorrhage: study protocol of a planned prospective study (MBI01) [J]. Trauma Emerg Surg, 2021,Epub ahead of print. [16]杨伊林,官卫,夏为民,等.血清神经元特异性烯醇化酶对重型颅脑损伤患者的预后评价[J].中华神经医学杂志,2003,2(5):361-363. |